UTHR Competitors
United Therapeutics Corporation
$543.15
+$10.03(+1.88%)
74
Overall
80
Value
75
Tech
68
Quality
Market Cap
$22.87B
Volume
494.81K
52W Range
$409.07 - $609.35
Target Price
$649.94
UTHR competitors: LLY, GILD, TEVA, PFE, BAX. United Therapeutics Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
UTHR Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| LLY Eli Lilly and Company | $1240.34 | $1.18T | $33.56 | 0.54% | 66 |
| GILD Gilead Sciences, Inc. | $153.07 | $193.67B | $-0.47 | 2.12% | 76 |
| TEVA Teva Pharmaceutical Industries Limited | $41.31 | $48.36B | $1.94 | - | 66 |
| PFE Pfizer Inc. | $29.43 | $168.60B | $2.95 | 5.84% | 70 |
| BAX Baxter International Inc. | $25.09 | $13.07B | $2.04 | 0.16% | 63 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UTHR | $543.15 | +1.9% | 494.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get United Therapeutics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW